BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14513370)

  • 1. Differential enhancement of collagen crosslink excretion in cases of osteosarcoma and chondrosarcoma.
    Açil Y; Springer I; Behrens P; Ullrich KP; Hedderich J; Bruns J
    J Cancer Res Clin Oncol; 2003 Oct; 129(10):583-8. PubMed ID: 14513370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridinoline cross-links as markers for primary and secondary bone tumors.
    Behrens P; Bruns J; Ullrich KP; Açil Y; Gille J
    Scand J Clin Lab Invest; 2003; 63(1):37-44. PubMed ID: 12729068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen crosslink excretion and staging of oral cancer.
    Springer IN; Terheyden H; Dunsche A; Czech N; Suhr MA; Tiemann M; Hedderich J; Açil Y
    Br J Cancer; 2003 Apr; 88(7):1105-10. PubMed ID: 12671712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes with age in the urinary excretion of hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP).
    Açil Y; Brinckmann J; Notbohm H; Müller PK; Bätge B
    Scand J Clin Lab Invest; 1996 May; 56(3):275-83. PubMed ID: 8761532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency.
    Kamel S; Brazier M; Rogez JC; Vincent O; Maamer M; Desmet G; Sebert JL
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3717-21. PubMed ID: 8855828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new method of monitoring osteomyelitis.
    Springer IN; Wiltfang J; Dunsche A; Lier GC; Bartsch M; Warnke PH; Barth EL; Terheyden H; Russo PA; Czech N; Acil Y
    Int J Oral Maxillofac Surg; 2007 Jun; 36(6):527-32. PubMed ID: 17418531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of collagen crosslink excretion in patients with oral squamous cell carcinoma and analysis of tissue samples.
    Springer IN; Terheyden H; Suhr MA; Warnke P; Dunsche A; Tiemann M; Açil Y
    Br J Cancer; 2003 Nov; 89(9):1722-8. PubMed ID: 14583776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic determination of 3-hydroxypyridinium derivatives as new markers of bone resorption.
    Kamel S; Brazier M; Desmet G; Picard C; Mennecier I; Sebert J
    J Chromatogr; 1992 Feb; 574(2):255-60. PubMed ID: 1618957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periosteal chondrosarcoma: a case report and review of the literature.
    Putti TC; Kahn LB; Aprin H
    Arch Pathol Lab Med; 1997 Jan; 121(1):70-4. PubMed ID: 9111097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration of collagen cross-links in human dentin bears no relation to the individual age.
    Açil Y; Springer IN; Prasse JG; Hedderich J; Jepsen S
    Int J Legal Med; 2002 Dec; 116(6):340-3. PubMed ID: 12461641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiological work-up of primary malignant bone tumours.
    Taconis WK; van der Eyken JW
    Diagn Imaging Clin Med; 1985; 54(1):28-38. PubMed ID: 3855725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple molecular forms of pyridinolines cross-links excreted in human urine evaluated by chromatographic and immunoassay methods.
    Kamel S; Brazier M; Neri V; Picard C; Samson L; Desmet G; Sebert JL
    J Bone Miner Res; 1995 Sep; 10(9):1385-92. PubMed ID: 7502711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 cases.
    Sopta J; Dordević A; Tulić G; Mijucić V
    J Cancer Res Clin Oncol; 2008 Feb; 134(2):147-52. PubMed ID: 17653766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Osteochondrosarcoma: clinical and morphological comparisons].
    Bulycheva IV; Makhson AN; Kuz'min IV; Pavlenko TV; Zhukov AG; Abramovich MS; Iskindirova AK
    Arkh Patol; 2008; 70(5):51-6. PubMed ID: 19137787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do pathological fractures influence survival and local recurrence rate in bony sarcomas?
    Bramer JA; Abudu AA; Grimer RJ; Carter SR; Tillman RM
    Eur J Cancer; 2007 Sep; 43(13):1944-51. PubMed ID: 17698347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linked elastin and collagen degradation products in the urine of patients with scleroderma.
    Stone PJ; Korn JH; North H; Lally EV; Miller LC; Tucker LB; Strongwater S; Snider GL; Franzblau C
    Arthritis Rheum; 1995 Apr; 38(4):517-24. PubMed ID: 7718005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathologic diagnosis of de-differentiated chondrosarcoma].
    Huang J; Zhang HZ; Zheng L; Zhou J; Jiang ZM
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):820-3. PubMed ID: 20193457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant tumors primary in bone (osteosarcoma, chondrosarcoma, fibrosarcoma, malignant giant cell tumor).
    Bonfiglio M
    Proc Natl Cancer Conf; 1970; 6():721-30. PubMed ID: 5272232
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature].
    Anract P; Tomeno B; Forest M
    Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(8):669-80. PubMed ID: 7638395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of glucose-containing oligosaccharides in urines of orthopedic patients.
    Tokunaga M; Wakamatsu E; Yosizawa Z
    Tohoku J Exp Med; 1979 May; 128(1):71-9. PubMed ID: 287216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.